| |
| |
|
| Insider
Information: |
Krenitsky Kevin |
| Relationship: |
President |
| City: |
New York |
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
210,261 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$32,873 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
210,261 |
|
|
| Total
Value |
$32,873 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Enzo Biochem Inc |
ENZ |
President, Enzo Clinic... |
2010-01-29 |
17,600 |
2009-10-15 |
0 |
Premium* |
|
|
Foundation Medicine, Inc. |
FMI |
Chief Commercial Offic... |
2014-10-01 |
140,611 |
|
0 |
Premium* |
|
|
Opgen Inc |
OPGN |
President |
2016-05-19 |
52,050 |
2015-05-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OPGN |
Opgen Inc |
President |
• – – |
2016-05-19 |
4 |
B |
$0.00 |
$0 |
D/D |
43,716 |
52,050 |
2.66 |
- |
|
| OPGN |
Opgen Inc |
President |
• – – |
2015-05-08 |
4 |
B |
$6.00 |
$50,004 |
D/D |
8,334 |
8,334 |
2.74 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer & SVP |
• – – |
2014-10-01 |
4 |
S |
$18.75 |
$1,313 |
D/D |
(70) |
140,611 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer & SVP |
• – – |
2014-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
203 |
140,681 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer & SVP |
• – – |
2014-07-01 |
4 |
S |
$27.20 |
$1,877 |
D/D |
(69) |
140,681 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer & SVP |
• – – |
2014-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
203 |
140,750 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer & SVP |
• – – |
2014-04-09 |
4 |
A |
$29.94 |
$97,305 |
D/D |
3,250 |
140,750 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer & SVP |
• – – |
2013-09-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
137,500 |
|
- |
|
| ENZ |
Enzo Biochem Inc |
President, Enzo Clinical Labs |
• – – |
2010-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
17,600 |
0 |
- |
|
| ENZ |
Enzo Biochem Inc |
President, Enzo Clinical Labs |
• – – |
2009-10-15 |
4 |
B |
$7.70 |
$50,828 |
D/D |
6,600 |
6,600 |
2.74 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
